TCTMD

Bioresorbable PFO/ASD Closure Device Shows Promise, but More Research Needed

Initial data looking at safety and efficacy of an interatrial septal occluder with a bioresorbable frame show promise for closing atrial septal defects (ASDs), but the study authors suggest a redesign ...
Medscape

Transcatheter PFO and ASD closure safe and effective, aided by intracardiac ultrasound guidance

Rochester, MN - A new case series of patients with a previous stroke suggests that transcatheter device closure of patent foramen ovale (PFO) and atrial septal defect (ASD) is safe and eliminated ...
Medscape

Another Device Choice for Atrial Septal Defect Closure

May 31, 2007 (Seattle, WA) - The pivotal trial of a new device approved for the percutaneous closure of atrial septal defects (ASD)--the HELEX septal occluder (WL Gore and Associates, Flagstaff, ...
EurekAlert!

Structural Heart features studies on ASD closure and disparities in Watchman device access

NEW YORK - March 12, 2019-The Cardiovascular Research Foundation (CRF) is pleased to announce that the latest issue of Structural Heart: The Journal of the Heart Team features original research ...
TCTMD

First Patient Enrolled in GORE® Septal Occluder Clinical Study for Atrial Septal Defect

FLAGSTAFF, Ariz.--W. L. Gore & Associates today reported the first patient enrolled in the GORE® Septal Occluder Clinical Study evaluating the safety and efficacy of the new GORE Septal Occluder in ...